These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4926926)

  • 1. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 2. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin therapy: data on the pharmacodynamics of the antibiotic derived from clinical practice].
    Angeli G; Pomarelli P
    Clin Ter; 1975 Jun; 73(5):461-4. PubMed ID: 1139866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of rifampicin in urinary tract infections by double blind method].
    Hayashida K; Eto K; Shigematsu S
    Jpn J Antibiot; 1970 Aug; 23(4):411-5. PubMed ID: 4923673
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study on rifamicin pharmacodynamics].
    Curci G; Ninni A; Di Mezza F
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):293-314. PubMed ID: 5307453
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of clinical effect between rifampicin and aminobenzylpenicillin in urinary tract infections by double blind method].
    Narahashi K; Momose S
    Hinyokika Kiyo; 1970 Dec; 16(12):781-6. PubMed ID: 4925066
    [No Abstract]   [Full Text] [Related]  

  • 11. [Absorption, distribution, metabolism and excretion of rifampicin (3-(4-methyl-1-piperazinyl-iminomethyl) rifamycin SV) in the rat].
    Akimoto T; Ono K; Nanpo T
    Jpn J Antibiot; 1970 Jun; 23(3):250-6. PubMed ID: 5312377
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of rifampicin in experimental animals and in man].
    Curci G; Ninni A
    Lotta Tuberc; 1971; 41(3):354-66. PubMed ID: 5291093
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical and biological properties of rifampicin.
    Furesz S
    Antibiot Chemother; 1970; 16():316-51. PubMed ID: 5002304
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of rifampicin for urinary tract infection].
    Kobayashi H; Takahashi Y; Sawanishi K; Tomoyoshi T; Matsuo M
    Hinyokika Kiyo; 1971 Jun; 17(6):429-42. PubMed ID: 4934923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical application of rifampicin to common infections (author's transl)].
    Nakagawa K; Watanabe K; Suzuki T
    Jpn J Antibiot; 1974 Apr; 27(2):69-72. PubMed ID: 4603394
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicologic and pharmacologic aspects of rifampin.
    Radner DB
    Chest; 1973 Aug; 64(2):213-6. PubMed ID: 4199024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of rifampicin in single and repeated administration to patients with inflammatory processes in the lungs of nontuberculotic etiology].
    Makarenkova RV; Kopeiko IP
    Antibiotiki; 1977 Mar; 22(3):259-60. PubMed ID: 848920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antitubercular drugs and their clinical use].
    Pregowski W
    Pol Tyg Lek; 1971 Feb; 26(7):244-7. PubMed ID: 4994370
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of meals on rifampicin absorption.
    Siegler DI; Bryant M; Burley DM; Citron KM; Standen SM
    Lancet; 1974 Jul; 2(7874):197-8. PubMed ID: 4135611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.